alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1

                                   Form 10-QSB
                             Arete Industries, Inc.
                          Quarter ended March 31, 2005


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In connection with the Quarterly Report of Arete Industries, Inc. (the
"Company") on Form 10-QSB for the period ending March 31, 2005, as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), I,
Thomas P. Raabe, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

     (1) The Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2) The information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.




Dated:  May 16, 2005            By:  /s/ Thomas P. Raabe
                                     ------------------------------------------
                                     Thomas P. Raabe, Chief Executive Officer
                                     and Interim Chief Financial Officer of
                                     the Registrant
EXHIBIT 32.1



                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002


In  connection  with  the  Quarterly  Report  of  Arete  Industries,  Inc.  (the
"Company")  on Form 10-QSB for the period ended March 31, 2004 as filed with the
Securities and Exchange Commission on the date hereof (the "Report"),  I, Thomas
P. Raabe,  certify,  pursuant to 18 U.S.C.  ss. 1350, as adopted pursuant to ss.
906 of the Sarbanes-Oxley Act of 2002, that:

     (1) The Report fully  complies  with the  requirements  of section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
material  respects,  the  financial  condition  and result of  operations of the
Company.


Dated: May 17, 2004                         By:  /s/ Thomas P. Raabe
                                                 ------------------------------
                                                 Chief Executive Officer and
                                                 Interim Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE> 7
<RESTATED>
<MULTIPLIER> 1
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<EXCHANGE-RATE>                                      1
<DEBT-HELD-FOR-SALE>                                 0
<DEBT-CARRYING-VALUE>                                0
<DEBT-MARKET-VALUE>                                  0
<EQUITIES>                                           0
<MORTGAGE>                                           0
<REAL-ESTATE>                                        0
<TOTAL-INVEST>                                       0
<CASH>                                               0
<RECOVER-REINSURE>                                   0
<DEFERRED-ACQUISITION>                               0
<TOTAL-ASSETS>                                       0
<POLICY-LOSSES>                                      0
<UNEARNED-PREMIUMS>                                  0
<POLICY-OTHER>                                       0
<POLICY-HOLDER-FUNDS>                                0
<NOTES-PAYABLE>                                      0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             0
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                         0
<PREMIUMS>                                           0
<INVESTMENT-INCOME>                                  0
<INVESTMENT-GAINS>                                   0
<OTHER-INCOME>                                       0
<BENEFITS>                                           0
<UNDERWRITING-AMORTIZATION>                          0
<UNDERWRITING-OTHER>                                 0
<INCOME-PRETAX>                                      0
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                         0
<EPS-PRIMARY>                                     3.97
<EPS-DILUTED>                                     3.89
<RESERVE-OPEN>                                       0
<PROVISION-CURRENT>                                  0
<PROVISION-PRIOR>                                    0
<PAYMENTS-CURRENT>                                   0
<PAYMENTS-PRIOR>                                     0
<RESERVE-CLOSE>                                      0
<CUMULATIVE-DEFICIENCY>                              0


</TABLE>
<TABLE> <S> <C>

<ARTICLE> 9
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1996
<PERIOD-START>                             JAN-01-1996
<PERIOD-END>                               DEC-31-1996
<CASH>                                          78,442
<INT-BEARING-DEPOSITS>                              22
<FED-FUNDS-SOLD>                                30,000
<TRADING-ASSETS>                                     0
<INVESTMENTS-HELD-FOR-SALE>                      4,170
<INVESTMENTS-CARRYING>                         148,083
<INVESTMENTS-MARKET>                           147,665
<LOANS>                                        497,429
<ALLOWANCE>                                    (6,578)
<TOTAL-ASSETS>                                 790,073
<DEPOSITS>                                     717,113
<SHORT-TERM>                                     3,751
<LIABILITIES-OTHER>                              5,502
<LONG-TERM>                                      4,000
<COMMON>                                         7,966
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                         88
<OTHER-SE>                                           0
<TOTAL-LIABILITIES-AND-EQUITY>                 790,073
<INTEREST-LOAN>                                 42,861
<INTEREST-INVEST>                                9,280
<INTEREST-OTHER>                                 1,272
<INTEREST-TOTAL>                                53,413
<INTEREST-DEPOSIT>                              16,024
<INTEREST-EXPENSE>                                 703
<INTEREST-INCOME-NET>                           36,686
<LOAN-LOSSES>                                    2,113
<SECURITIES-GAINS>                                   0
<EXPENSE-OTHER>                                 27,134
<INCOME-PRETAX>                                 15,403
<INCOME-PRE-EXTRAORDINARY>                      10,654
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    10,654
<EPS-PRIMARY>                                     0.87
<EPS-DILUTED>                                     0.86
<YIELD-ACTUAL>                                    6.03
<LOANS-NON>                                      2,438
<LOANS-PAST>                                       229
<LOANS-TROUBLED>                                    45
<LOANS-PROBLEM>                                 12,738
<ALLOWANCE-OPEN>                               (5,907)
<CHARGE-OFFS>                                  (1,856)
<RECOVERIES>                                       414
<ALLOWANCE-CLOSE>                                6,578
<ALLOWANCE-DOMESTIC>                             3,074
<ALLOWANCE-FOREIGN>                                  0
<ALLOWANCE-UNALLOCATED>                          3,504
        

</TABLE>
## Contact Information

Bethesda MD20892-2350

veronica.nagle@nih.gov

## Summary

Veronica Nagle recently graduated from the College of William and Mary with a bachelor of science degree in biology. She is currently applying to graduate schools to pursue a degree in molecular biology or pharmacology. Within the Laboratory of Skin Biology, Ms. Nagle is characterizing the homeobox transcription factor DLX3’s role in epidermal differentiation by studying its signaling networks. She is also collaborating with Stuart H. Yuspa, M.D., within the Laboratory of Cancer Biology and Genetics at the National Cancer Institute to determine DLX3’s impact on epidermal tumor development. 

July 2017

Back to Top
**EXHIBIT 23.1**

 

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

 

We consent to the incorporation by reference in Registration Statement No. 333-72756 of Dynacq Healthcare, Inc. of our report dated June 18,2004, with respect to the consolidated financial statements and schedule of Dynacq Healthcare, Inc. included in this Annual Report (Form 10-K) for the year ended August 31, 2003. 

 

/s/ Killman, Murrell & Co., P.C. 

 

Killman, Murrell & Co., P.C. 

Houston,Texas 

July 30, 2004
#### In the Matter of the Claim of Xiao Qing Liu, Appellant, v Richline Group/Bel-Oro et al., Respondents. Workers’ Compensation Board, Respondent.

Submitted October 5, 2009;

decided December 1, 2009

Reported below, 2009 NY Slip Op 81679(U).

Motion for leave to appeal dismissed upon the ground that the order sought to be appealed from does not finally determine the proceeding within the meaning of the Constitution. Motion for poor person relief dismissed as academic.
Exhibit 31.1
**CERTIFICATION**
I, Ronald E. Eibensteiner, certify that:
1. I have reviewed this annual report on 10-KSB for the year ended December 31,2003 of Spectre Gaming, Inc.;
2. Based on my knowledge, this report does not contain any untrue statement ofa material fact or omit to state a material fact necessary to make thestatements made, in light of the circumstances under which such statements weremade, not misleading with respect to the period covered by this annual report;
3. Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all material respectsthe financial condition, results of operations and cash flows of the registrantas of, and for, the periods presented in this report;
4. The registrant’s other certifying officers and I are responsible forestablishing and maintaining disclosure controls and procedures (as defined inExchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:
 a) designed such disclosure controls and procedures, or causedsuch disclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to theregistrant, including its consolidated subsidiaries, is made knownto us by others within those entities, particularly during theperiod in which this annual report is being prepared;  b) evaluated the effectiveness of the registrant’s disclosurecontrols and procedures and presented in this report our conclusionsabout the effectiveness of the disclosure controls and procedures,as of the end of the period covered by this report based on suchevaluation; and  c) disclosed in this report any change in the registrant’sinternal control over financial reporting that occurred during theregistrant’s most recent fiscal quarter that has materiallyaffected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer and I have disclosed, based on ourmost recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of registrant’s board ofdirectors (or persons performing the equivalent function):
 a) all significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reportingwhich are reasonably likely to adversely affect the registrant’sability to record, process, summarize and report financialinformation; and  b) any fraud, whether or not material, that involves managementor other employees who have a significant role in the registrant’sinternal control over financial reporting.        Date: March 24, 2004 /s/  Ronald E. Eibensteiner  By: Ronald E. Eibensteiner   President and Chief Executive Officer  
35
EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Arête Industries, Inc. (the Company) on
Form 10-Q for the period ending June 30, 2012, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Donald W. Prosser, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| | --- | ---------------------------------------------------------------------------------------------------------------------------------------------------



|                       |  |  |  |     |  |                                           
|---------------------- |  |  |  | --- |  | ------------------------------------------
|Dated: August 15, 2012 |  |  |  | By: |  | /s/ Donald W. Prosser                     
|                       |  |  |  |     |  | Donald W. Prosser, Chief Executive Officer
Exhibit 99.2








Certification of Chief Financial Officer of


Borden Chemicals and Plastics Limited
Partnership





This certification is provided pursuant to Section 906 of the Public Company Accounting Reform
and Investor Protection Act of 2002 and accompanies the Quarterly Report on Form 10-Q (the Form 10-Q) for the quarterly period ended September 30, 2002, of Borden Chemicals and Plastics Limited Partnership (the Issuer). I,
Robert R. Whitlow, Jr., the Chief Financial Officer of the Issuer, certify that, to the best of my knowledge:





| | (i) |  | the Form 10-Q fully complies with the requirements of section 13(a) or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a) or 78o(d)); and
| | --- |  | -------------------------------------------------------------------------------------------------------------------------------------------------------------




| | (ii) |  | the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Issuer.
| | ---- |  | ------------------------------------------------------------------------------------------------------------------------------------------------------







Date: December 18, 2002

/S/    ROBERT R. WHITLOW, JR.Robert R. Whitlow, Jr.Chief Financial Officer
<TABLE> <S> <C>

<ARTICLE>              5
<LEGEND>       
This schedule contains summary financial information extracted from the 
consolidated financial statements of Uroplasty, Inc. and subsidiaries as of
and for the year ended March 31, 1998, and is qualified in its entirety by 
reference to such financial statements. 
</LEGEND>
       
<S>                                 <C>
<PERIOD-TYPE>                        Year
<FISCAL-YEAR-END>                    Mar-31-1998
<PERIOD-START>                       Apr-01-1997                
<PERIOD-END>                         Mar-31-1998
<CASH>                                   889,541
<SECURITIES>                                   0
<RECEIVABLES>                            766,835
<ALLOWANCES>                              64,930
<INVENTORY>                              294,424
<CURRENT-ASSETS>                       2,135,428
<PP&E>                                 1,261,059
<DEPRECIATION>                           216,529
<TOTAL-ASSETS>                         3,281,544
<CURRENT-LIABILITIES>                    621,182
<BONDS>                                        0
<COMMON>                                  41,915
<PREFERRED-MANDATORY>                          0
<PREFERRED>                                    0
<OTHER-SE>                             2,008,841
<TOTAL-LIABILITY-AND-EQUITY>           2,050,756
<SALES>                                4,335,908
<TOTAL-REVENUES>                       4,335,908
<CGS>                                    937,978
<TOTAL-COSTS>                          2,736,288
<OTHER-EXPENSES>                        (129,503)
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                       (20,732)
<INCOME-PRETAX>                          519,701
<INCOME-TAX>                             111,860
<INCOME-CONTINUING>                      407,841
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                             407,841
<EPS-PRIMARY>                                .10
<EPS-DILUTED>                                .09
        

</TABLE>
EXHIBIT 32.1
                                  ------------


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Quarterly Report of BSD Medical Corporation (the
"Company") on Form 10-QSB for the period ended May 31, 2006, as filed with the
Securities and Exchange Commission on the date hereof (the "Report"), I, Hyrum
A. Mead, President (Principal Executive Officer) of the Company, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

         (1) the Report fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934; and

         (2) the information contained in the Report fairly presents, in all
material respects, the financial condition and result of operations of the
Company.


                                      /s/ Hyrum A. Mead
                                      -----------------
                                      Hyrum A. Mead
                                      President (Principal Executive Officer)
                                      July 17, 2006
Exhibit 10.8






EXHIBIT 10.8

 




AMENDMENT NUMBER FIVE

TO THE

CONSTELLATION BRANDS, INC. 

LONG-TERM STOCK INCENTIVE PLAN




This Amendment Number Five to the Constellation Brands, Inc. Long-Term Stock Incentive Plan (the "Plan") is adopted pursuant to Section 19 of the Plan by the Board of Directors of Constellation Brands, Inc. (the "Company"), acting in its capacity as the Committee under the Plan, and by the stockholders of the Company. Capitalized terms used herein which are not otherwise defined shall have the meanings ascribed to them in the Plan and Annex A thereto.




The Plan is hereby amended to increase the number of shares of the Company’s Common Stock with respect to which Awards may be made under the Plan to forty million shares by amending the first sentence of the first paragraph of Section 4 of the Plan to read in its entirety as follows:




The total number of shares of the Company’s Common Stock available for Awards under the Plan in the 

aggregate shall not exceed forty million shares.

 

In witness whereof, Constellation Brands, Inc. has caused this instrument to be executed as of July 20, 2004.




 


 




 



	
CONSTELLATION BRANDS, INC.

	 	 
	 	 
	 	
/s/ W. Keith Wilson

	
Name:
	
W. Keith Wilson

	
Title:
	
Executive Vice President and Chief

Human Resources Officer
#### Childs *v.*The State.

There was no error in overruling the motion for a new trial.

April 16, 1894.

Indictment for assault with intent to murder. Before Judge Bartlett. Bibb superior court. November term, 1893.

James H. Blount, Jr., for plaintiff in error.

W. H. Felton, Jr., solicitor-general, *contra.*

*Judgment affirmed.*
#### IN THE MATTER OF C.T. and B.T.

No. 175A07

(Filed 12 October 2007)

Appeal pursuant to N.C.G.S. § 7A-30(2) from the decision of a divided panel of the Court of Appeals, 182 N.C. App. 166, 641 S.E.2d 414 (2007), dismissing respondent’s appeal from an order entered 17 March 2006 by Judge Edward A. Pone in District Court, Cumberland County. Heard in the Supreme Court 11 September 2007.

*Beth A. Hall, Attorney Advocate, for appellee Guardian ad Litem, and Elizabeth Kennedy-Gumee, Staff Attorney, for petitioner-appellee Cumberland County Department of Social Services.*

*Lisa Skinner Lefler for respondent-appellant father.*

PER CURIAM.

AFFIRMED.
INTERNATIONAL BRANDS MANAGEMENT GROUP LTD. 

_____________, 2008

DC Management Group LLC 

25 East 22nd Street

New York, NY 10010

Gentlemen:

This letter will confirm our agreement that, commencing on the effective date (“Effective Date”) of the registration statement for the initial public offering (“IPO”) of the securities of International Brands Management Group Ltd. (the “Company”) and continuing until the earlier of the consummation by the Company of a “Business Combination” or the Company’s liquidation (as described in the Company’s IPO prospectus) (the “Termination Date”), DC Management Group LLC shall make available to the Company certain office and administrative services as may be required by the Company from time to time, situated at 25 East 22nd Street, New York, NY 10010. In exchange therefor, the Company shall pay DC Management Group LLC the sum of $10,000 on the Effective Date and the first day of each month thereafter until the Termination Date.

 


	
                         
 	
                         
 	
                        Very truly yours,
 
	
                         
 	
                         
 	
                         
 
	
                         
 	
                         
 	
                        INTERNATIONAL BRANDS MANAGEMENT GROUP LTD.
 
	
                         
 	
                         
 	
                         
 	
                         
 
	
                          
 	
                         
 	
                        By: 
 	
                          
 
	
                         
 	
                         
 	
                         
 	
                        Name:
 
	
                         
 	
                         
 	
                         
 	
                        Title:
 




 


	
                        AGREED TO AND ACCEPTED BY:
 	
                         
 	
                         
 
	
                         
 	
                         
 	
                         
 
	
                        DC MANAGEMENT GROUP LLC
 	
                         
 	
                         
 
	
                         
 	
                         
 	
                         
 	
                         
 	
                         
 
	
                        By: 
 	
                          
 	
                         
 	
                         
 	
                         
 
	
                         
 	
                        Name:
 	
                         
 	
                         
 	
                         
 
	
                         
 	
                        Title: